Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.22B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$504M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$335M |
| 4 |
Bank of America
BAC
|
+$324M |
| 5 |
TSMC
TSM
|
+$297M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.62B |
| 2 |
Meta Platforms (Facebook)
META
|
+$471M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$396M |
| 4 |
NVIDIA
NVDA
|
+$391M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.25% |
| 2 | Technology | 2.31% |
| 3 | Consumer Discretionary | 1.61% |
| 4 | Financials | 1.35% |
| 5 | Healthcare | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSCI
11551
PUT
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $59.8K | ﹤0.01% |
5,725
-45,000
| -89% | -$599K |
|
|
JCTC
11552
Jewett-Cameron Trading
JCTC
$10.3M
| $59.8K | ﹤0.01% |
+10,376
| New | +$58.5K |
|
11553
CALL
BioAtla
BCAB
$5.23M
| $59.8K | ﹤0.01% |
446
-136
| -23% | -$24.5K |
|
|
ADVM
11554
DELISTED
Adverum Biotechnologies
ADVM
| $59.7K | ﹤0.01% |
8,321
+7,060
| +560% | +$49.9K |
|
11555
BiomX
PHGE
$3.53M
| $59.7K | ﹤0.01% |
1,029
+811
| +372% | +$51.3K |
|
|
DDL
11556
Dingdong
DDL
$488M
| $59.6K | ﹤0.01% |
+15,452
| New | +$74.8K |
|
|
PVL
11557
CALL
Permianville Royalty Trust
PVL
$60.1M
| $59.5K | ﹤0.01% |
24,900
-26,200
| -51% | -$71.2K |
|
|
ICD
11558
DELISTED
Independence Contract Drilling, Inc.
ICD
| $59.5K | ﹤0.01% |
18,249
-24,515
| -57% | -$94.3K |
|
|
DWTX
11559
Dogwood Therapeutics
DWTX
$78.9M
| $59.5K | ﹤0.01% |
+6,472
| New | +$51.5K |
|
11560
CALL
BioCardia
BCDA
$17.7M
| $59.4K | ﹤0.01% |
2,020
-9,713
| -83% | -$322K |
|
11561
CALL
iHeartMedia
IHRT
$416M
| $59.3K | ﹤0.01% |
+15,200
| New | +$96.9K |
|
11562
Finance of America Companies
FOA
$169M
| $59.2K | ﹤0.01% |
4,771
+2,301
| +93% | +$35.1K |
|
11563
PUT
Aurora
AUR
$11.4B
| $58.9K | ﹤0.01% |
42,400
-1,000
| -2% | -$1.48K |
|
|
SOLO
11564
PUT
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
| $58.8K | ﹤0.01% |
113,000
+94,800
| +521% | +$76.7K |
|
11565
PUT
Fate Therapeutics
FATE
$304M
| $58.7K | ﹤0.01% |
+10,300
| New | +$62.1K |
|
|
BURU
11566
CALL
DELISTED
NUBURU INC
BURU
| $58.5K | ﹤0.01% |
+110
| New | +$138K |
|
|
WKEY
11567
WISeKey
WKEY
$79.1M
| $58K | ﹤0.01% |
11,053
-1,878
| -15% | -$10.9K |
|
|
KZR
11568
PUT
DELISTED
Kezar Life Sciences
KZR
| $57.9K | ﹤0.01% |
+1,850
| New | +$107K |
|
11569
NextNav
NN
$2.65B
| $57.9K | ﹤0.01% |
+28,512
| New | +$76.4K |
|
11570
ESS Tech
GWH
$14.1M
| $57.8K | ﹤0.01% |
2,774
+1,152
| +71% | +$32.1K |
|
11571
CALL
Mammoth Energy Services
TUSK
$152M
| $57.8K | ﹤0.01% |
13,700
-23,000
| -63% | -$137K |
|
11572
CALL
Alzamend Neuro
ALZN
$8.06M
| $57.5K | ﹤0.01% |
99
-49
| -33% | -$36.8K |
|
11573
Antelope Enterprise Holdings
AEHL
$5.77M
| $57.5K | ﹤0.01% |
+1
| New | +$35.6K |
|
|
AZRE
11574
CALL
DELISTED
Azure Power Global Limited
AZRE
| $57.3K | ﹤0.01% |
23,000
-3,500
| -13% | -$11.9K |
|
11575
Momentus
MNTS
$93.8M
| $57.2K | ﹤0.01% |
8
-6
| -43% | -$60.8K |
|
Similar funds
Jeff Yass's Q1 2023 Portfolio in Review
As of Q1 2023, Jeff Yass held 14,310 positions worth $470B, up 19% from $395B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q1 2023 filing shows 2,075 new, 5,756 increased, 4,471 reduced and 1,856 closed positions. Its largest new stake was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M. The largest sale was Tesla, an estimated $1.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2023 buy was Schwab US Aggregate Bond ETF: 2,949,950 shares worth $69.2M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.22B increase.
- Jeff Yass's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.62B.
- Jeff Yass fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $61.5M.
- Jeff Yass's ten largest holdings make up 30% of its $470B portfolio in Q1 2023.
- Jeff Yass opened 2,075 new positions and closed 1,856 in Q1 2023.
- Jeff Yass's portfolio value rose 19% quarter-over-quarter to $470B.
Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.